Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	101.23	91.3	57.97	55.26	53.34	64.68
Revenue Growth (YoY)	60.81%	57.50%	4.90%	3.61%	-17.54%	-10.42%
Cost of Revenue	39	35.84	25.83	22.77	18.95	22.17
Gross Profit	62.23	55.47	32.14	32.49	34.39	42.52
Selling, General & Admin	72.6	64.29	37.98	35.47	34.49	43.84
Research & Development	1.69	1.34	0.92	0.87	0.66	0.93
Operating Expenses	74.28	65.63	38.89	36.34	35.14	44.77
Operating Income	-12.05	-10.16	-6.76	-3.85	-0.75	-2.25
Interest Expense / Income	3.2	2.94	1.69	1	5.98	5.77
Other Expense / Income	-11.95	-12.06	-0.03	-	-	0.1
Pretax Income	-3.3	-1.04	-8.42	-4.85	-6.73	-8.12
Income Tax	-1.64	-1.7	0.07	0	0.3	0.1
Net Income	-1.66	0.66	-8.49	-4.85	-7.02	-8.22
Shares Outstanding (Basic)	130	119	94	85	28	13
Shares Outstanding (Diluted)	130	127	94	85	28	13
Shares Change	19.57%	34.76%	10.10%	199.85%	116.50%	12.12%
EPS (Basic)	-0.01	0.01	-0.09	-0.06	-0.25	-0.63
EPS (Diluted)	-0.01	0.01	-0.09	-0.06	-0.25	-0.63
Free Cash Flow	-14.56	-10.8	-6.9	-1.45	-2.04	-0.96
Free Cash Flow Per Share	-0.11	-0.09	-0.07	-0.02	-0.07	-0.07
Gross Margin	61.47%	60.75%	55.44%	58.79%	64.48%	65.73%
Operating Margin	-11.91%	-11.13%	-11.65%	-6.97%	-1.41%	-3.48%
Profit Margin	-1.64%	0.72%	-14.64%	-8.77%	-13.17%	-12.71%
Free Cash Flow Margin	-14.38%	-11.82%	-11.90%	-2.63%	-3.82%	-1.48%
EBITDA	3.6	5.08	-5.43	-2.52	1.33	0.79
EBITDA Margin	3.56%	5.56%	-9.37%	-4.56%	2.49%	1.22%
Depreciation & Amortization	3.71	3.17	1.29	1.33	2.08	3.14
EBIT	-0.11	1.9	-6.72	-3.85	-0.75	-2.35
EBIT Margin	-0.10%	2.08%	-11.60%	-6.97%	-1.41%	-3.63%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).